全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

上调核糖核酸酶抑制因子对小鼠黑色素瘤B16细胞生长和凋亡的影响

, PP. 1331-1337

Keywords: 核糖核酸酶抑制因子,B细胞,增殖,凋亡,ILK/PIK/AKT信号通路

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的研究核糖核酸酶抑制因子(ribonucleaseinhibitor,RI)基因表达对小鼠黑色素瘤B16细胞生长和凋亡的影响。方法构建RI真核表达质粒pIRES2-EGFP-RI稳定转染B16细胞,未转染和空质粒作对照组(pIRES2-EGFP组),经G418筛选出阳性克隆。RT-PCR、免疫印迹和免疫荧光检测RI的表达;MTT检测细胞的增殖;流式细胞术、TUNEL及Hochest33342检测细胞周期及凋亡;Westernblot检测凋亡相关的蛋白及ILK/PI3K/AKT信号通路关键分子的表达;分别注射各组B16细胞到C57/BL小鼠建立移植瘤模型,观察肿瘤的生长及肿瘤微血管的变化,进一步分析ILK/PI3K/AKT信号通路蛋白在肿瘤组织中的表达。结果转染RI细胞组的RImRNA和蛋白表达水平显著升高;MTT结果显示B16-RI细胞较对照组增殖能力明显降低,流式细胞结果显示B16-RI细胞的S期明显增加,表明RI表达上调后细胞生长停滞于S期(P<0.05);Hochest33342、TUNEL及AnnexinV和PI双染色流式法细胞凋亡检测结果证实,B16-RI细胞与对照组相比出现大量凋亡细胞(P<0.01)及典型凋亡形态特征:染色质凝集,核碎裂和明亮的蓝色荧光等;Westernblot结果显示,与对照组相比,B16-RI细胞中ILK、p-Akt、p-GSK3β、Bcl-2及β-catenin的表达明显降低,而活化的Caspase-3和Bax蛋白的表达显著增加(P<0.01);动物的移植瘤实验结果显示,转RI组的小鼠的瘤重显著降低(P<0.01),瘤组织中的血管密度明显减少,同时ILK、p-Akt、p-GSK3β、β-catenin在瘤组织中表达减少。TUNEL肿瘤组织凋亡检测结果与体外细胞一致。结论过表达RI可能通过调节ILK/PI3K/AKT信号通路显著抑制了小鼠黑色素瘤B16细胞的生长并诱导了B16细胞的凋亡。

References

[1]  Shapiro R. Cytoplasmic ribonuclease inhibitor[J]. Methods Enzymol, 2001, 341:? 611-628. [2]Dickson K A, Kang D K, Kwon Y S, et al. Ribonuclease inhibitor regulates neovascularization by human angiogenin[J]. Biochemistry, 2009, 48(18):? 3804-3806. [3]Nekrasov A N, Zinchenko A A. Structural features of the interfaces in enzyme-inhibitor complexes[J]. J Biomol Struct Dyn, 2010, 28(1):? 85-96. [4]McDonald P C, Oloumi A, Mills J, et al. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival[J]. Cancer Res, 2008, 68(6):? 1618-1624. [5]潘湘阳, 李红彦, 姚雪, 等. 核糖核酸酶抑制因子过表达抑制B16细胞的侵袭和转移[J]. 第三军医大学学报, 2012, 34(4):? 284-289. [6]Xiong D, Liou Y, Shu J, et al. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway[J]. Exp Mol Pathol, 2014, 96(3):? 411- 421. [7]Chen J, Ou-Yang X, Gao J, et al. Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials[J]. Mol Cell Biochem, 2011, 349(1/2):? 83-95. [8]Fu P, Chen J, Tian Y, et al. Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor[J]. Cancer Gene Ther, 2005, 12(3):? 268-275. [9]Kim Y J, Park S J, Choi E Y, et al. PTEN modulates miR-21 processing via RNA-regulatory protein RNH1[J]. PLoS One, 2011, 6(12):? e28308. [10]Dobreva I, Fielding A, Foster L J, et al. Mapping the integrin-linked kinase interactome using SILAC[J]. J Proteome Res, 2008, 7(4):? 1740-1749. [11]Zhu J, Pan X, Zhang Z, et al. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells[J]. Cell Signal, 2012, 24(6):? 1323-1332. [12]Ibaragi S, Yoshioka N, Kishikawa H, et al. Angiogenin-stimulated? rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia[J]. Mol Cancer Res, 2009, 7(3):? 415-424. [13]Troussard A A, McDonald P C, Wederell E D, et al. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival[J]. Cancer Res, 2006, 66(1):? 393-403. [14]Malla R, Gopinath S, Alapati K, et al. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas[J]. PLoS One, 2010, 5(10):? e13731.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133